Flexjak ER 11mg Tablet
Images are for reference. Actual packaging may vary.
Tofacitinib (11mg)
1 units • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Tofacitinib inhibits Janus kinases, disrupting signaling pathways involved in inflammation and immune responses.
Medical applications
Flexjak ER 11mg Tablet contains Tofacitinib 11mg, an oral medication primarily used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Tofacitinib belongs to a class of drugs known as Janus kinase (JAK) inhibitors, which work by blocking specific enzymes involved in the inflammatory process, thereby reducing inflammation and immune system overactivity.
This extended-release formulation allows for a controlled and sustained release of the active ingredient, ensuring consistent therapeutic effects throughout the day with once-daily dosing. Flexjak ER is prescribed to patients who have had an inadequate response or intolerance to other disease-modifying antirheumatic drugs (DMARDs). By modulating the immune response, it helps alleviate symptoms such as joint pain, swelling, stiffness, and skin lesions, improving overall physical function and quality of life.
Patients should take this medication exactly as directed by their healthcare provider and report any side effects, which may include infections, headache, diarrhea, or elevated cholesterol levels. Regular monitoring of blood counts and liver function is recommended during treatment. Flexjak ER should be used with caution in individuals with a history of infections or liver disease, and it is not suitable for pregnant or breastfeeding women without medical advice.
Pyrrolo Pyrimidine Derivative
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Flexjak ER 11mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Flexjak ER 11mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Flexjak ER 11mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Flexjak ER 11mg Tablet may be needed. Please consult your doctor.
Exercise Caution
Flexjak ER 11mg Tablet does not usually affect your ability to drive.
Consult Doctor
Flexjak ER 11mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Flexjak ER 11mg Tablet may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Flexjak ER 11mg Tablet







